COVID-19 News
UP-developed Covid-19 test kits approved for commercial use By Joyce Ann L. Rocamora
MANILA - The Food and Drug Administration (FDA) has approved the coronavirus disease 2019 (Covid-19) test kits developed by the University of the Philippines-National Institutes of Health (UP-NIH).
(Image grabbed from DOST Secretary Fortunato dela Peña’s Facebook page)
“The Food and Drug Administration (FDA) has now approved the Real-Time PCR for the detection of COVID-19 manufactured by the Manila HealthTek, Inc. for commercial use,” the FDA said in an advisory on Friday night.
week with coronavirus detection kit
“This is the first locally made PCR based COVID-19 test kit approved by the FDA which was developed in collaboration with the University of the Philippines-National Institute of Health The UP-developed test kit was (UP-NIH), funded by the Department of previously approved by the FDA for Science and Technology (DOST),” the field trial. FDA said. Upon the company’s submission of necessary requirements, the FDA issued a certification for the COVID-19 test kit “to be allowed for commercial use”.
Aside from the locally-made PCR based test kit, the FDA has also approved one additional rapid test kit on Friday, namely, “Hightop SARSCoV-2 IgM/IgG Antibody”, bringing the total number of Covid-19 approved READ: UP-NIH to do 1K tests per test kits to 30. (PNA) APRIL 4-10, 2020 |
49
